Published: 8 July 2015
Author(s): V. Thijs, K. Butcher
Section: Review Article

Strokes, whether ischaemic or haemorrhagic, are the most feared complications of atrial fibrillation (AF) and its treatment. Vitamin K antagonists have been the mainstay of stroke prevention. Recently, direct oral anticoagulants have been introduced. The advantages and disadvantages of these treatment strategies have been extensively discussed. In this narrative review, we discuss dilemmas faced by primary care clinicians in the context of stroke and transient ischaemic attack (TIA) in patients with AF.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.